Brian Baranick Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 day, 7 hours ago
Brian Baranick has an estimated net worth of at least $11.9 million*, as of yesterday. They own 103,874 shares of EXAS stock. They have sold 18,071 shares of EXAS stock since 2021, for an estimated $1.2 million.
Brian Baranick $EXAS SEC Form 4 Insider Trading
Brian Baranick has filed a total of 14 insider trades in $EXAS since 2021. Their most recent trade was a sale of 2,858 shares, made on Nov 04, 2025. Their largest trade was a sale of 2,858 shares, made on Nov 04, 2025. We estimate that they now own 103,874 shares of $EXAS, worth an estimated $10.7 million.
Insider Trading at $EXAS
There have been a total of 150 insider trades reported at $EXAS since 2021, with 19,500 shares purchased and 559,166 shares sold. The most active insider traders in $EXAS stock have been Jeffrey Thomas Elliott, Sarah Condella, and Kevin T Conroy. The most recent trade was a sale of 5,000 shares reported by JACOB A ORVILLE (EVP, GM, Screening), made on Nov 19, 2025.
History of Insider Stock Trades by Brian Baranick
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
EXAS
|
Sale | 2,858 | Nov 04, 2025 | Nov. 6, 2025, 6:29 p.m. |
|
EXAS
|
Sale | 929 | Oct 08, 2024 | Oct. 9, 2024, 5 p.m. |
|
EXAS
|
Sale | 929 | Sep 18, 2024 | Sept. 19, 2024, 5 p.m. |
|
EXAS
|
Sale | 110 | May 01, 2024 | May 2, 2024, 7 p.m. |
|
EXAS
|
Sale | 924 | Apr 02, 2024 | April 3, 2024, 7:30 p.m. |
|
EXAS
|
Sale | 2,323 | Mar 01, 2024 | March 4, 2024, 9:36 p.m. |
|
EXAS
|
Sale | 2,027 | Feb 27, 2024 | Feb. 28, 2024, 8:34 p.m. |
|
EXAS
|
Sale | 1,093 | Feb 22, 2024 | Feb. 23, 2024, 8:57 p.m. |
|
EXAS
|
Sale | 895 | Feb 21, 2024 | Feb. 22, 2024, 8:36 p.m. |
|
EXAS
|
Sale | 879 | Jan 02, 2024 | Jan. 4, 2024, 6:17 p.m. |
|
EXAS
|
Sale | 1,350 | Aug 07, 2023 | Aug. 8, 2023, 4:09 p.m. |
|
EXAS
|
Sale | 1,932 | Feb 28, 2023 | March 1, 2023, 6:16 p.m. |
|
EXAS
|
Sale | 838 | Feb 22, 2023 | Feb. 23, 2023, 5:18 p.m. |
|
EXAS
|
Sale | 984 | Aug 05, 2022 | Aug. 8, 2022, 12:02 p.m. |
$EXAS Executives and Stock Owners with Insider Trades
-
Jeffrey Thomas Elliott, Chief Financial Officer
-
Sarah Condella, EVP, Human Resources
-
Kevin T Conroy, President and CEO
-
Jacob A Orville, General Manager, Screening
-
James Herriott, General Counsel
-
Brian Baranick, Gen. Mgr., Precision Oncology
-
Everett Cunningham, Chief Commercial Officer
-
Sarah Condella, SVP, Human Resources
-
Jacob A Orville, General Manager, New Ventures
-
James Herriott, SVP, General Counsel & Sec
-
Brian Baranick, EVP, GM, Precision Oncology
-
D Scott Coward, Chief Administrative Officer
-
Brian Baranick, EVP, GM., Precision Oncology
-
D Scott Coward, Chief Legal Officer
-
Jacob A Orville, EVP, GM, Screening
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.